Cargando…

Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications

The extracellular matrix (ECM) offers the opportunity to create a biomaterial consisting of a microenvironment with interesting biological and biophysical properties for improving and regulating cell functions. Animal-derived ECM are the most widely used as an alternative to human tissues that are o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayon, Adrien, Helle, Deborah, Francius, Gregory, Vincourt, Jean-Baptiste, Regnault, Véronique, Dumas, Dominique, Menu, Patrick, El Omar, Reine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234273/
https://www.ncbi.nlm.nih.gov/pubmed/35769101
http://dx.doi.org/10.3389/fbioe.2022.884069
_version_ 1784736032096256000
author Fayon, Adrien
Helle, Deborah
Francius, Gregory
Vincourt, Jean-Baptiste
Regnault, Véronique
Dumas, Dominique
Menu, Patrick
El Omar, Reine
author_facet Fayon, Adrien
Helle, Deborah
Francius, Gregory
Vincourt, Jean-Baptiste
Regnault, Véronique
Dumas, Dominique
Menu, Patrick
El Omar, Reine
author_sort Fayon, Adrien
collection PubMed
description The extracellular matrix (ECM) offers the opportunity to create a biomaterial consisting of a microenvironment with interesting biological and biophysical properties for improving and regulating cell functions. Animal-derived ECM are the most widely used as an alternative to human tissues that are of very limited availability. However, incomplete decellularization of these tissues presents a high risk of immune rejection and disease transmission. In this study, we present an innovative method to extract human ECM derived from the Wharton’s jelly (WJ-ECMaa) of umbilical cords as a novel biomaterial to be used in tissue engineering. WJ-ECMaa was very efficiently decellularized, suggesting its possible use in allogeneic conditions. Characterization of its content allowed the identification of type I collagen as its main component. Various other matrix proteins, playing an important role in cell adhesion and proliferation, were also detected. WJ-ECMaa applied as a surface coating was analyzed by fluorescent labeling and atomic force microscopy. The results revealed a particular arrangement of collagen fibers not previously described in the literature. This biomaterial also presented better cytocompatibility compared to the conventional collagen coating. Moreover, it showed adequate hemocompatibility, allowing its use as a surface with direct contact with blood. Application of WJ-ECMaa as a coating of the luminal surface of umbilical arteries for a use in vascular tissue engineering, has improved significantly the cellularization of this surface by allowing a full and homogeneous cell coverage. Taking these results together, our novel extraction method of human ECM offers a very promising biomaterial with many potential applications in tissue engineering such as the one presented direct in vascular tissue engineering. Further characterization of the composition and functionality will help explore the ways it can be used in tissue engineering applications, especially as a scaffold or a surface coating.
format Online
Article
Text
id pubmed-9234273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92342732022-06-28 Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications Fayon, Adrien Helle, Deborah Francius, Gregory Vincourt, Jean-Baptiste Regnault, Véronique Dumas, Dominique Menu, Patrick El Omar, Reine Front Bioeng Biotechnol Bioengineering and Biotechnology The extracellular matrix (ECM) offers the opportunity to create a biomaterial consisting of a microenvironment with interesting biological and biophysical properties for improving and regulating cell functions. Animal-derived ECM are the most widely used as an alternative to human tissues that are of very limited availability. However, incomplete decellularization of these tissues presents a high risk of immune rejection and disease transmission. In this study, we present an innovative method to extract human ECM derived from the Wharton’s jelly (WJ-ECMaa) of umbilical cords as a novel biomaterial to be used in tissue engineering. WJ-ECMaa was very efficiently decellularized, suggesting its possible use in allogeneic conditions. Characterization of its content allowed the identification of type I collagen as its main component. Various other matrix proteins, playing an important role in cell adhesion and proliferation, were also detected. WJ-ECMaa applied as a surface coating was analyzed by fluorescent labeling and atomic force microscopy. The results revealed a particular arrangement of collagen fibers not previously described in the literature. This biomaterial also presented better cytocompatibility compared to the conventional collagen coating. Moreover, it showed adequate hemocompatibility, allowing its use as a surface with direct contact with blood. Application of WJ-ECMaa as a coating of the luminal surface of umbilical arteries for a use in vascular tissue engineering, has improved significantly the cellularization of this surface by allowing a full and homogeneous cell coverage. Taking these results together, our novel extraction method of human ECM offers a very promising biomaterial with many potential applications in tissue engineering such as the one presented direct in vascular tissue engineering. Further characterization of the composition and functionality will help explore the ways it can be used in tissue engineering applications, especially as a scaffold or a surface coating. Frontiers Media S.A. 2022-06-13 /pmc/articles/PMC9234273/ /pubmed/35769101 http://dx.doi.org/10.3389/fbioe.2022.884069 Text en Copyright © 2022 Fayon, Helle, Francius, Vincourt, Regnault, Dumas, Menu and El Omar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Fayon, Adrien
Helle, Deborah
Francius, Gregory
Vincourt, Jean-Baptiste
Regnault, Véronique
Dumas, Dominique
Menu, Patrick
El Omar, Reine
Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications
title Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications
title_full Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications
title_fullStr Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications
title_full_unstemmed Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications
title_short Characterization of an Innovative Biomaterial Derived From Human Wharton’s Jelly as a New Promising Coating for Tissue Engineering Applications
title_sort characterization of an innovative biomaterial derived from human wharton’s jelly as a new promising coating for tissue engineering applications
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234273/
https://www.ncbi.nlm.nih.gov/pubmed/35769101
http://dx.doi.org/10.3389/fbioe.2022.884069
work_keys_str_mv AT fayonadrien characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT helledeborah characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT franciusgregory characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT vincourtjeanbaptiste characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT regnaultveronique characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT dumasdominique characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT menupatrick characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications
AT elomarreine characterizationofaninnovativebiomaterialderivedfromhumanwhartonsjellyasanewpromisingcoatingfortissueengineeringapplications